Showing results (931-940 of 1,107) with videos related to

Sort By:
Pageof 111
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077C D Britten, E K Rowinsky, S D Baker, et al.
Journal of Clinical Lipidology|October 2, 2013
Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care settingRoss J Simpson, Kaan Tunceli, Dena R Ramey, et al.
Clinical Genetics|December 29, 2025
Retinal Pigment Epitheliopathy due to Sub-Optimal Recycling of Vitamin A (RESORVA): A Novel RDH11-Related PhenotypeKirk A J Stephenson, Zhuo Shao, Anupreet Tumber, et al.
The Journal of Infection|November 23, 2021
Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studiesS A Behnood, R Shafran, S D Bennett, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|December 20, 2003
Vector and tensor polarization lifetimes for a stored deuteron beamB V Przewoski, V A Anferov, H O Meyer, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 7, 2016
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaqueDavid R Powell, Jason P Gay, Melinda Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2011
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancerG R Blumenschein, F Kabbinavar, H Menon, et al.
Nature Communications|October 13, 2022
Chronic intake of high dietary sucrose induces sexually dimorphic metabolic adaptations in mouse liver and adipose tissueErin J Stephenson, Amanda S Stayton, Aarti Sethuraman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancerJ F Bishop, J Dewar, G C Toner, et al.
Lung Cancer (Amsterdam, Netherlands)|January 7, 2014
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancerJoe J Stephenson, John Nemunaitis, Anil A Joy, et al.
Pageof 111